Keeping Up with AI: 6 Trends Transforming Commercial Life Sciences in 2020

Clay Hausmann and Matthew Van Wingerden As a new decade begins (or is it the last year of the 2011-2020 decade? A debate for a different day), we’re on the cusp of a full-scale transformation in life sciences. As mentioned in Gartner’s recent report, Predicts 2020: Life Science CIOs Must Digitalize for Business Growth1 (Gartner […]

Bayer and Aktana at VECMS: Creating the Customer-Centered Commercial Model with Intelligent Engagement

This year’s European Veeva Commercial and Medical Summit welcomed more than 1,300 professionals from the life sciences industry in Barcelona. At the event, Gerhard Arnhofer, VP, Head of Integrated Multichannel Marketing at Bayer, and David Ehrlich, CEO of Aktana, presented how Bayer is partnering with Aktana to incorporate AI across commercial operations to create greater […]

Compensating the AI-Directed Sales Force

It’s a topic that will only become more pressing as artificial intelligence (AI) solidifies its status as a “must-have” tool for sales teams across industries. From financial services to life sciences, companies are working to not only define new compensation structures, but also overcome operational hurdles and drive internal adoption. These trends mean reps may […]

AI is a Must-Have for Life Sciences Commercial Teams: Aktana CEO David Ehrlich Interviewed on The Bio Report

October 22, 2019/Aktana/Decision Support

Applying machine learning and artificial intelligence (AI) to the commercial process in the biopharmaceutical industry is rapidly becoming a critical success factor in organizations. In a recent interview on The Bio Report podcast, Aktana CEO and President David Ehrlich sat down with host Danny Levine to discuss how intelligent technology is closing the loop between […]

Intelligent Engagement in the LatAm Market: Q&A with Eduardo Alonso, Aktana Head of Customer Success

The Veeva Commercial Summit in Sao Paulo is right around the corner, and we’re getting ready by sitting down with one of the newest members of our customer success team, Eduardo Alonso. With 21 years experience working at major pharmaceutical companies and consulting firms in Brazil, Eduardo has a wealth of insight about the current […]

Novartis and Aktana at Veeva Summit: Building the AI-Driven Commercial Engagement Model

May 30, 2019/Lauren Schivley/Events

We returned as a platinum sponsor once again to the Veeva Commercial and Medical Summit, which welcomed over 1,700 attendees in Philadelphia this year. At the event, Eva Martins, Global Head of Innovative Models and Commercial Transformation at Novartis, and Derek Choy, Co-founder and COO at Aktana, presented how Novartis is partnering with Aktana to […]

Three Principles of Agile HCP Engagement

The demand for AI-driven personalization and cohesive experiences across channels is prompting a change in go-to-market execution. Healthcare providers (HCPs) are demanding a more connected experience. It’s important, now more than ever, for commercial teams to shift away from the traditional annual, cycle-driven execution model to more a more frequent, agile approach. This will help […]

Industry Leaders Come Together to Discuss Intelligent Customer Engagement at the 2019 Aktana Innovators Forum

We recently hosted our annual Aktana Innovators Forum in New York City. The event brought together life sciences leaders for a series of discussions about the role of artificial intelligence (AI) in the new commercial model. 2019 will be a transformative year for many life sciences companies and the forum offered opportunities to connect with […]

A view from Japan: Helping reps better understand customer needs

March 27, 2019/Aktana/Field Sales

Meeting the expectations of healthcare providers (HCPs) should be obvious, but often this sentiment is easier said than done, especially in the life sciences industry. The complex landscape of this market in Japan makes this task even more challenging, filled with complicated regulations, contracts, and various stakeholders. How can we ensure our reps are providing […]

The Democratization of Machine Learning in Commercial Life Sciences

Machine learning is easily one of the most heavily discussed buzzwords within life sciences in the past few years. Defined as a process where large amounts of data and algorithms give a machine the ability to learn how to perform tasks and identify patterns, it often gets a bad rap. Although there are clear benefits […]